| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 6.694 | 30.586 | 26.603 | 36.496 | 19.605 | 243 | 1.643 | 3.194 | 2.915 |
| Total Income - EUR | - | 6.694 | 30.715 | 26.620 | 36.564 | 19.682 | 243 | 1.699 | 3.194 | 2.915 |
| Total Expenses - EUR | - | 7.010 | 11.569 | 17.508 | 21.587 | 10.854 | 599 | 2.874 | 4.350 | 3.235 |
| Gross Profit/Loss - EUR | - | -316 | 19.146 | 9.112 | 14.978 | 8.828 | -356 | -1.175 | -1.156 | -320 |
| Net Profit/Loss - EUR | - | -514 | 18.224 | 8.314 | 13.881 | 8.295 | -363 | -1.226 | -1.156 | -477 |
| Employees | - | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Diabnutrimedika Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 4.403 | 20.582 | 12.324 | 19.915 | 19.910 | 912 | 1.829 | 1.454 | 1.953 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 1.006 | 73 | 0 | 3.375 | 642 | 140 | 504 | 131 |
| Cash | - | 4.403 | 19.576 | 12.251 | 19.915 | 16.535 | 270 | 1.688 | 950 | 1.822 |
| Shareholders Funds | - | -470 | 17.763 | 11.783 | 19.113 | 19.689 | 430 | -794 | -1.947 | -2.414 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 4.883 | 2.819 | 542 | 801 | 221 | 482 | 2.623 | 3.402 | 4.366 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Diabnutrimedika Srl